0000905718-22-000007.txt : 20220103 0000905718-22-000007.hdr.sgml : 20220103 20220103174554 ACCESSION NUMBER: 0000905718-22-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIKLER MATTHEW CENTRAL INDEX KEY: 0001195414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 22503276 MAIL ADDRESS: STREET 1: VIROPHARMA INCORP STREET 2: 405 EAGLEVIEW BLVD CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-484-8805 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 ownership.xml X0306 4 2021-12-31 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001195414 WIKLER MATTHEW C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 1 0 0 0 Common Stock 2021-12-31 4 A 0 7859 0 A 290472 D On December 31, 2021, the Reporting Person was issued 7,859 shares of common stock, par value $0.0001 per share, pursuant to the Issuer's Amended and Restated 2013 Equity Compensation Plan. Such shares vest immediately upon grant. /s/ Keith A. Kucinski, attorney-in-fact for Matthew Wikler 2022-01-03